Javier Zulueta is a Respiratory physician affiliated with Mount Sinai Hospital. OpenAlex indexes 340 publications with 9,649 citations (h-index 48); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1111 Amsterdam Ave
New York, NY 100251716
Telephone
212-523-4000Provider last certified this registry record 30 Nov 2020.
Clinical trials
- Sarilumab Treatment In cytoKinE Storm Caused by Infection With COVID-19
Sponsor: Clinica Universidad de Navarra, Universidad de Navarra
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Siemens Medical Solutions USA, Inc.Program year20251 payment
- Viatris Specialty LLCProgram year20251 payment
- INTUITIVE SURGICAL, INC.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
100%Corticosteroid74.4%Trelegy Ellipta66%Fluticasone Propionate34%Part D<11 patientsbeta2-Adrenergic Agonist25.6%Albuterol Sulfate Hfa100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges
Journal of Thoracic Oncology
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Allison McGeer
Mount Sinai Hospital
Scott Sicherer, MD
Mount Sinai Hospital
Ulrich Specks
Mount Sinai Hospital
Jorge Sánchez‐Guerrero
Mount Sinai Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”